InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: louieblouie post# 6475

Saturday, 05/18/2013 1:59:50 PM

Saturday, May 18, 2013 1:59:50 PM

Post# of 426853
No I meant 7-26-2012. That was Vascepa's approval date and when NCE will be backdated from. NCE clock is already ticking, it's 5 yrs from the date of approval. As time passes an Anchor approval 12-20-2913 NME is almost equal to NCE for the 7-26-2012 approval of Marine. I should have been more clear.

NCE on 7-26-12, 13, 14, 15, 16, 7-26-17 expiration.

NME for Anchor approval 12-20-13, 14, 15, 12-2016 expiration.

NCE for Anchor approval 12-20-13, 14, 15, 16, 17, 12-20-2018 expiration.

All possible.

Also, if Amarin can perform a small Phase 3 combo the could get 3 yrs NME under a 505 (b) 2 application.

By the end of 2014 Amarin will have 30 ish patents related to Marine, Anchor, Icosapent, capsule for Icosapent, REDUCE-IT, and combos. So any of the above exclusivities provide Amarin's Patent lawyers time to work.

Williams



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News